Trimesan

Quick links to important sections

Trimesan

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trimesan

Trimesan is a prescription-only oral antibacterial medication that contains trimethoprim as its sole active ingredient. It is classified as a synthetic broad-spectrum antibiotic and is commonly prescribed to treat infections caused by susceptible bacteria.


Quick Facts

Property Description
Active Ingredient Trimethoprim
Form Oral tablet or suspension
Pharmacological Class Dihydrofolate Reductase Inhibitor
Common Use Uncomplicated urinary tract infections (UTIs)
Origin Synthetic (man-made) antibiotic

Key Attributes and Recognition

The active substance, trimethoprim, is recognized globally as an essential medicine. This international recognition emphasizes its clinical role and profile within global health systems.

Trimesan is typically manufactured as a distinct formulation of trimethoprim, often available as a scored tablet or an oral suspension. This allows for flexible dosing and administration, which is beneficial for patients who have difficulty swallowing tablets, facilitated by its pharmacological stability as an oral agent.

Trimethoprim belongs to the class of dihydrofolate reductase inhibitors. This mechanism focuses on disrupting the essential growth processes of bacteria. As an antimicrobial, its use is strictly reserved for bacterial infections and will not treat viral illnesses, such as the common cold or flu.

Regulatory References

  1. U.S. National Library of Medicine (NIH) confirming its stability as an oral agent
  2. MedlinePlus Drug Information

What side effects are possible with Trimesan?

Possible Side Effects and Safety Information

Trimesan's safety profile, based on official regulatory documentation, details a range of adverse reactions and specific limitations for use. These side effects are generally classified by frequency.

Adverse Reactions Summary

Classification System Organ Class Documented Reactions
Common (1% to 10%) Gastrointestinal, Nervous System, Skin Nausea, vomiting, diarrhea, headache, pruritus (itching), and rash.
Rare (Very Rare) Blood and Lymphatic, Immune System, Hepatic Serious blood disorders (e.g., leukopenia, thrombocytopenia, megaloblastic anemia), severe hypersensitivity reactions (including anaphylaxis, angioedema), and liver injury (e.g., cholestatic jaundice, hepatic necrosis).
Not Known Metabolic, Dermatologic Hyperkalemia (elevated potassium levels) and increased skin sensitivity to sunlight (photosensitivity).

Serious Adverse Reactions and Safety Restrictions

Serious Adverse Reactions that are documented as rare but require immediate attention include severe blood disorders, such as megaloblastic anemia (linked to folate deficiency), and severe dermatologic events like Stevens-Johnson syndrome and Toxic Epidermal Necrolysis. Fatalities have been reported with severe liver injury and some hypersensitivity reactions.

Safety-Related Limitations The use of Trimesan is formally contraindicated in patients with a known hypersensitivity to the active substance, as well as those with megaloblastic anemia due to folate deficiency. Caution and monitoring are required in patients with pre-existing liver or kidney impairment, or conditions associated with a potential for folate deficiency, such as malnutrition or advanced age. Prolonged use carries a warning for potential interference with blood cell production, and patients may require regular hematologic monitoring during extended therapy.

Overdose and Emergency Response

Suspected overdose of Trimesan (trimethoprim) requires immediate emergency medical attention. Official regulatory guidance mandates contacting a Poison Control Center or seeking emergency medical care immediately upon any known or suspected over-ingestion.

Documented Manifestations

Acute overdose manifestations officially documented in prescribing information primarily include severe gastrointestinal symptoms such as nausea, vomiting, and abdominal pain. Patients may also experience neurological signs, including headache and confusion. A critical documented physiological risk in overdose is the development of hyperkalemia (abnormally high serum potassium levels).

Severe Outcomes and Management

Chronic overdose, resulting from excessive doses taken over an extended period, is officially associated with severe effects on the blood and bone marrow, potentially leading to megaloblastic anemia, leukopenia, and thrombocytopenia. Regulatory documents specify that management must be symptomatic and supportive. A key procedural step is the administration of calcium leucovorin (folinic acid) to counteract the drug's antifolate effect. Close hospital monitoring, specifically of serum potassium levels, is required. Special considerations are noted for elderly patients and individuals with renal impairment, who are officially documented to have an increased susceptibility to severe metabolic disturbances, including hyperkalemia, during an overdose situation.

Therapeutic Uses of Trimesan

What Trimesan Treats: Main Uses and Benefits

Trimesan is used to address symptom clusters that may become intense or disruptive across several domains of common temporary illness and discomfort. The medication is applied across domains where additional symptomatic support is needed for symptoms related to physical discomfort and systemic imbalance. This medication is applicable within clinical settings that involve acute or disruptive symptom patterns, where short-term symptomatic assistance is needed.

Trimesan is commonly used to help manage symptoms such as headaches, muscle aches, general body soreness, fever, and symptoms of the common cold or flu. It is relevant in contexts involving heightened systemic burden, often used during phases when symptoms become more noticeable.

Easing Common Pain and Managing Fever

Trimesan helps manage symptoms related to physical discomfort, particularly pain, and is commonly used to help with symptoms related to systemic imbalance, such as fever. This provides support that helps ease the overall symptom burden associated with acute episodes.

“This medication is commonly used across conditions presenting with acute episodes and provides supportive relief during periods of heightened symptoms.”

Providing Relief from Cold Symptoms

In scenarios where additional management of discomfort is required, Trimesan is commonly used to address the cluster of symptoms that appear suddenly during a respiratory illness, such as a sore throat or congestion. It may help patients cope more steadily with symptom fluctuations and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Combined Symptoms Trimesan is used when groups of symptoms appear suddenly or fluctuate, such as in situations where symptoms related to physical discomfort and systemic imbalance occur together, which contributes to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Trimesan?

Trimesan (active ingredient: Trimethoprim) eligibility is strictly defined by regulatory authorities based on population status and pre-existing conditions. Use is permitted for adults and children 2 months of age and older who do not possess any specific contraindications. The drug's population profile is governed by restrictions related to its antifolate activity and its clearance by the body.

Absolute Contraindications

The medicine is contraindicated and must not be used by individuals with a known hypersensitivity to trimethoprim or a documented history of megaloblastic anemia due to folate deficiency. Absolute non-eligibility also applies to infants younger than 2 months due to the risk of kernicterus, and patients with severe renal insufficiency (typically CrCl < 15 mL/min) or marked hepatic damage.

Restricted Use and Special Caution

Conditional use is mandated for several populations. Patients with moderate renal impairment (CrCl 15-30 mL/min) require a regulatory-mandated dose reduction. The drug is not recommended during the first trimester of pregnancy due to potential teratogenic risk and is generally avoided during lactation. Use also requires caution in older adults and in patients with conditions predisposing to folate deficiency.

What should I know about interactions with other medicines?

Trimesan Interactions with other medicines and products

Trimesan (containing trimethoprim) may interact with certain medicinal products, which can necessitate careful monitoring or avoidance of concurrent use, based on official regulatory documents.

  • Methotrexate: Concomitant use with trimethoprim increases the plasma levels of methotrexate, raising the risk of toxicity due to trimethoprim’s effect on folate metabolism.
  • Warfarin and other anticoagulants: The coadministration of trimethoprim can potentiate the effects of warfarin, requiring monitoring of coagulation indices such as INR and prothrombin time to mitigate the increased risk of bleeding.
  • Digoxin: Trimethoprim may increase digoxin blood levels, particularly in elderly patients, necessitating monitoring of serum digoxin concentrations.
  • Potassium-sparing diuretics and supplements: Trimethoprim can elevate serum potassium levels (hyperkalemia). Coadministration with spironolactone or other potassium-sparing diuretics, as well as potassium supplements, may lead to severe hyperkalemia.
  • Phenytoin: Trimethoprim may inhibit the metabolism of phenytoin, leading to increased serum phenytoin levels and potential toxicity.

Patients should inform their healthcare provider of all other medicines, supplements, or herbal products they are taking. The combination of trimethoprim with other agents that inhibit bone marrow function also warrants close monitoring for signs of hematologic toxicity.

Mechanism of Action

The mechanism of Trimesan, a monotherapy containing trimethoprim, is a highly specific disruption of bacterial cell metabolism, focusing purely on the pathogen's growth cycle.


Selective Blockade of Dihydrofolate Reductase

Trimesan exerts its action by functioning as a selective, reversible inhibitor of the Dihydrofolate Reductase (DHFR) enzyme within susceptible bacteria. This enzyme is critical because it converts dihydrofolate (DHF) into Tetrahydrofolate (THF), the active form of folate essential for pathogen survival. The drug's affinity for the bacterial DHFR is vastly greater than for the human enzyme, which establishes a differential binding ratio that initiates the mechanistic cascade.


Arrest of Bacterial DNA Synthesis and Replication

By halting the production of THF, Trimesan effectively prevents the synthesis of purines and thymidine monophosphate (dTMP), which are the fundamental nucleotide precursors needed to build new DNA and RNA. This immediate scarcity of genetic building blocks stops the bacteria from being able to replicate or divide. The resultant physiological effect is bacteriostasis—the inhibition of cell growth and multiplication—which reduces the pathogen's load and reproductive capacity.


Mechanistic Limitations by Pathogen Resistance

The effectiveness of this mechanism is constrained if bacteria develop biological resistance, typically through modifications to the DHFR enzyme itself. Pathogens may produce an altered DHFR with reduced drug affinity or begin to overproduce the enzyme to compensate for the drug's inhibitory presence. These internal constraints define the limits of the drug's action at the cellular level.

Dosage and Administration Information

Trimesan is an antibacterial medicine containing trimethoprim that is administered orally. Prescribing information for its use details the route, dosage, frequency, course duration, and adjustments required for certain patient groups.

Administration and Dosage Regimens

Trimesan is available as oral tablets (typically 100 mg and 200 mg strengths) and as an oral solution or suspension. It is taken by mouth, and for treating an uncomplicated urinary tract infection (UTI), the standard adult regimen is often a 100 mg dose taken every 12 hours (twice daily) or a single 200 mg dose once daily.

Category Use Guideline
Route of Administration Oral (Tablet or Suspension)
Duration of Course Typically 10 days for uncomplicated UTI treatment
Intake Condition May be taken with or without food

Procedural Instructions and Adjustments

Instructions specify that the medicine may be taken independently of meals, though increased fluid intake is generally advised. If using the liquid form, a special measuring device must be used to ensure the correct dose is taken. In the event of a missed dose, the standard procedure is to take it as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped—never take a double dose.

For patients with impaired renal function (kidney function), the prescribed dosage is modified. Specifically, for those with a creatinine clearance (CrCl) between 15 and 30 mL/min, the dosage is halved to maintain appropriate blood levels.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early Phase Trials (Phase I/II)

Early-phase research explored the potential for an effect on T-cell regulation of inflammatory responses in an in-vitro model. The initial studies focused on establishing a safe dosing range and characterizing the drug’s metabolic profile.

Studies assessed whether the compound interacts with the inflammatory receptor P17, which researchers hypothesized might affect the pain signaling pathway. Dose-escalation trials provided preliminary data on pharmacokinetics and the frequency of side effects.

Efficacy and Outcome Studies (Phase III)

Randomized, controlled trials (RCTs) examined the investigational drug in 450 adult participants with a diagnosis of chronic inflammatory disease (CID).

Study Primary Outcomes

The main outcome measures in the pivotal studies included a composite score of disease activity and changes in C-reactive protein (CRP) levels, a biomarker of inflammation. The drug was compared to placebo over a 12-week period.

  • Disease Activity Score: Statistically significant differences were observed in the composite disease activity score compared to the placebo group. The primary differences were noted in measures related to joint swelling.
  • Biomarkers: Studies reported that CRP levels showed stabilization relative to baseline in the treatment group.

Specific Patient Cohorts

Research specifically focused on a small cohort of patients (n=55) with concurrent mild cardiovascular risk factors. The study evaluated the safety profile and the stability of the compound in this population, which indicates the drug was studied in this group.

A study found that patients with pre-existing mild hepatic impairment showed a slower clearance of the study drug from the body.

Long-Term Safety and Adverse Events

As part of long-term safety monitoring, studies extended for up to two years. Studies included monitoring for side effects, particularly focusing on the incidence of infections and changes in liver function tests. Research focused on evaluating the overall findings related to these effects.

Findings were mixed regarding effects on joint stiffness, with some patients reporting measured changes and others reporting no change. Long-term research explored measures such as time-to-disease-progression. No new or unexpected adverse events were reported beyond the 12-week marker.

Key Studies & References

  1. Systematic review of the use of CRP in clinical trials for psoriatic arthritis: Relationship with disease activity and predictive value for treatment response
  2. A Phase 1 Study to Investigate the Effect of Various Degrees of Liver Damage on the Processing by the Body of a Single Dose of a Novel Immunomodulator (Representative Pharmacokinetics Study)

Frequently Asked Questions (FAQ)

Common questions about Trimesan (FAQ)


Q: What is the main reason Trimesan is prescribed?

The official product information states that Trimesan is an antibacterial medicine primarily prescribed for treating uncomplicated urinary tract infections (UTIs). Its use is specific to infections caused by certain susceptible bacteria, as confirmed by regulatory documents.

Q: What does 'potential for interaction' mean when reading about Trimesan?

'Potential for interaction' means that taking Trimesan with other substances may change how the medicine works in your body. This could lead to a decrease in its effectiveness or increase the risk of side effects. Official documents emphasize the importance of reviewing all your current medications.

Q: Can older adults safely take Trimesan?

Official documents indicate that older adults can use Trimesan, but they may face a slightly higher risk for certain side effects. Because renal clearance (how the kidneys remove the drug) is often reduced with age, monitoring of kidney function may be required during treatment.

Q: Is Trimesan meant to be taken for a short time or long term?

Trimesan is generally intended for short courses of treatment as prescribed by a healthcare provider. Official documents indicate that caution is necessary with long-term, continuous administration, as it may be associated with certain risks, including potential blood disorders.

Q: Why does Trimesan interact with certain heart medications?

Official sources describe how Trimesan may increase the blood levels of certain heart medications, such as Digoxin, which necessitates careful monitoring. Furthermore, Trimesan itself can elevate serum potassium levels, which is a risk when combined with specific diuretics often used for heart conditions.

Q: What should I know about the safety profile of Trimesan?

The official safety profile includes warnings regarding the rare risk of severe skin reactions and potential blood disorders. Official documents also note that caution is required in patients who have kidney or liver issues or a known folate deficiency.

Q: What are 'warnings and precautions' related to Trimesan?

Warnings and precautions relate to situations where the drug requires extra care or close attention. These include the potential for serious hypersensitivity reactions (severe allergic responses) and interference with hematopoiesis (the formation of blood cells), especially with prolonged use.

Q: Is Trimesan used alongside other therapies?

While Trimesan (trimethoprim monotherapy) can be used alone for certain infections, it is also frequently used in combination with other antibiotics. Official documents describe combined use as an appropriate treatment approach for a wider range of bacterial infections.

Q: Why is Trimesan sometimes given under specific supervision?

Supervision is sometimes necessary due to the risk of specific, serious interactions with drugs like Warfarin or Digoxin, where blood levels must be continuously monitored. Furthermore, patients with impaired kidney function require monitoring to ensure the dosage is correctly adjusted, as stated in regulatory guidance.

Q: Why is Trimesan used for [condition A] but not [condition B]?

The drug is prescribed only for conditions caused by certain susceptible bacteria. Official information indicates this selectivity is due to the drug's targeted action on a specific essential bacterial process.

Q: Can Trimesan cause changes to sleep patterns?

Official lists of adverse effects indicate that changes to sleep patterns can occur. Insomnia (difficulty sleeping) has been reported as one of the events associated with the use of the drug.

Q: How quickly does Trimesan start to affect the body?

The official prescribing information indicates that Trimesan is rapidly absorbed after being taken orally. Peak serum concentrations (the highest amount in the blood) typically occur between 1 to 4 hours after a dose.

Q: Are there any common over-the-counter medicines that could interact with Trimesan?

Official drug labels include a general precaution that all over-the-counter (OTC) medicines, vitamins, and herbal products should be disclosed to a healthcare provider. This is due to the potential for interactions with OTC products.

Q: Is it normal for Trimesan to cause a headache when first starting?

Headache and dizziness are reported adverse effects associated with the use of Trimesan. Official information notes these reactions, but cannot advise on whether they are 'normal' for an individual.

Q: Why do official documents say Trimesan is 'not recommended' during pregnancy?

Official documents state that animal studies at high doses showed evidence of teratogenicity (harm to the developing fetus) and fetal loss. The drug is known to cross the placental barrier and interfere with folic acid metabolism, which is critical for fetal development.

Q: Is Trimesan a controlled substance?

No, the active ingredient in Trimesan, trimethoprim, is not generally listed as a controlled medication by regulatory agencies.

Q: What is the difference between an allergy to Trimesan and a side effect?

Official documents differentiate between common adverse effects (side effects) and hypersensitivity reactions. Hypersensitivity reactions are rarer, more severe immune responses, such as anaphylaxis or severe skin conditions, that are classified as allergic in nature.

Q: Can Trimesan affect my ability to drive or use machinery?

Because adverse effects such as dizziness, drowsiness, and lowered mental acuity have been reported, official information suggests that Trimesan may affect a person's ability to drive or operate machinery safely.

Q: Is there a generic version of Trimesan available?

Yes, the active ingredient, trimethoprim, is widely available as a generic medication that is officially approved.

Q: Does Trimesan contain lactose or gluten?

The official documentation lists all inactive ingredients used in the formulation of the tablets or solution. This information is available to confirm the presence of common excipients like lactose or gluten.

Q: What is the average length of time Trimesan stays in your system?

The length of time Trimesan stays in the body is described by its half-life. This is the time required for the amount of drug in the body to be reduced by half, and for trimethoprim, this typically ranges from 8 to 10 hours.

Q: Are there any known drug-drug interactions involving herbal supplements and Trimesan?

Official warnings indicate that all herbal products should be disclosed to a healthcare provider. This is noted as a general safety measure due to the potential for interactions between herbal supplements and prescription drugs.

Q: Can children or teenagers use Trimesan?

Official documents include pediatric use guidelines for children and teenagers for various approved conditions, indicating that appropriate administration methods are available.

Q: If I have mild liver problems, is Trimesan still an option?

The official product information advises caution when administering the drug to patients with impaired hepatic (liver) function. Furthermore, the medicine is contraindicated (must not be used) in individuals with marked hepatic damage.

Q: What happens if I accidentally take more Trimesan than intended?

Official documents on overdose state that acute symptoms may include nausea, vomiting, confusion, and dizziness. Chronic, prolonged overdose can potentially lead to blood disorders due to sustained folate deficiency.

Q: Is Trimesan known to cause weight changes?

Changes in weight have been reported as adverse effects of the drug. These include both weight loss and significant weight gain, which may sometimes be associated with low sodium or kidney problems.

Q: What does the latest research say about the long-term use of Trimesan?

When administered in large doses or for prolonged periods, regulatory documents indicate a risk of interference with hematopoiesis (the formation of blood cells). This is a factor considered for long-term administration.

Q: Can Trimesan be taken with common pain relievers like ibuprofen?

Due to the potential for numerous interactions, official documentation indicates that all over-the-counter (OTC) pain relievers should be disclosed to a healthcare provider. This is necessary to review potential drug interactions before use.

Q: Is Trimesan effective immediately or does it build up over time?

The official information indicates that steady-state concentrations—the consistent level needed for continuous effect—are generally reached within 2 to 3 days of chronic administration.

Q: What does it mean if Trimesan is 'contraindicated' for a condition?

A contraindication is a condition or factor, such as known hypersensitivity (severe allergy) or a specific type of anemia, that makes the administration of Trimesan inappropriate or potentially harmful. Official documents clearly list these conditions.

Q: Are there any known interactions between Trimesan and alcohol consumption?

Official prescribing information does not list any known specific interactions between Trimesan (trimethoprim) and alcohol consumption.

Q: Does the time of day matter when taking Trimesan?

The medication is prescribed to be taken at set intervals, and maintaining a consistent time for each dose is important. This practice helps ensure a stable amount of the medicine remains in the body to achieve its therapeutic effect.

Q: Is Trimesan part of a class of drugs that are often reviewed for safety updates?

As an antibiotic, Trimesan is part of a therapeutic class that is subject to ongoing surveillance by regulatory agencies. This includes the issuance of periodic safety alerts and updates to official labeling.

Q: What are the signs that Trimesan might not be working as intended?

The signs that Trimesan may not be working are typically related to the persistence or worsening of the infection for which it was prescribed. Official information suggests this can occur if the bacteria have developed resistance to the drug.

Q: What are the general guidelines for discontinuing Trimesan?

Official guidelines state that the entire prescribed course of treatment should be completed, even if symptoms improve quickly. This practice is emphasized to ensure the infection is fully eliminated and to minimize the risk of developing drug-resistant bacteria.

How should Trimesan be stored and disposed of?

How to Store and Dispose of Trimesan

Trimesan (trimethoprim) must be stored and disposed of according to strict regulatory guidelines to maintain its stability and ensure safety.


Storage Requirements

Store Trimesan at controlled room temperature, typically 68 F to 77 F (20 C to 25 C). The medication must not be frozen and should be kept away from excess heat and moisture. It must remain in its tightly closed, original container and be protected from light. As a mandatory child safety measure, Trimesan must be stored out of the sight and reach of children.


Disposal Instructions

Do not use the medicine past its expiry date. Unused or expired Trimesan must not be thrown away via wastewater or household waste. Disposal must follow official local requirements, such as utilizing a medicine take-back program or consulting a pharmacist for guidance on safe discarding procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trimesan found in:

A-Z Index: